Previous Meetings

GBCC 2019

Global Breast Cancer Conference 2019

10:00-11:15
Symposium 1
Tailoring Adjuvant Systemic Therapy
Venue: Premier Ballroom AB
  • Who Needs Systemic Chemotherapy?
    Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
  • Who Are Candidate for Ovarian Suppression & Extended Endocrine Therapy
    Masakazu Toi (Graduate School of Medicine, Kyoto Univ., Japan)
  • What's New for HER2 Positive Early Breast Cancer?
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
Panel Discussion 1
What Can We Do for the Excellent Responders of Neoadjuvant Chemotherapy?
Venue: Premier Ballroom C
  • Good Responders: Who Are They?
    Yong Wha Moon (CHA Bundang Medical Center, CHA Univ., Korea)
  • Can We Eliminate Surgery in Exceptionally Excellent Responders?
    Mark Basik (Segal Cancer Center, Canada)
  • Radiation Oncologist's View for Escalation or De-escalation
    Mi Young Kim (Kyungpook National Univ. Hospital, Korea)
Education Session 1
Recent Advance of Endocrine Treatment
Venue: 113-115
  • Optimal Sequence of Endocrine Treatment in Advanced Breast Cancer
    Sarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
  • Overcome of Endocrine Resistance
    Hiroji Iwata (Aichi Cancer Center, Japan)
  • Late Recurrence in ER-positive Breast Cancer: Risk Prediction & Treatment
    Ian Smith (The Royal Marsden NHS Foundation Trust, United Kingdom)
Oral Presentation 1
Venue: 107-109
  • BREAST CANCER RATE AND MORTALITY IN FLIGHT ATTENDANTS
    Michael Co (The Univ. of Hong Kong, Hong Kong)
  • HORMONE REPLACEMENT THERAPY AND BREAST CANCER RISK IN A NATIONWIDE POPULATION-BASED COHORT
    Tae-Kyung Yoo (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
  • ASSOCIATION BETWEEN OBESITY AND FIRMICUTES/BACTEROIDETES RATIO IN BREAST CANCER PATIENTS
    Jeongshin An (Ewha Womans Univ. Mokdong Hospital, Korea)
  • NOVEL FUSION GENES IDENTIFIED FROM MATCHED PRIMARY AND RECURRED BREAST CANCERS BY RNA-SEQUENCING
    Soojeong Choi (ASAN Medical Center, Korea)
  • BASAL AND IL-1β-INDUCED IL-8 IS SUPPRESSED BY CELASTROL IN TRIPLE NEGATIVE BREAST CANCER
    Yisun Jeong (Sungkyunkwan Univ. School of Medicine, Korea)
  • APPLICATION OF 3D PRINTED BREAST SURGICAL GUIDE FOR BREAST CONSERVING SURGERY IN DCIS PATIENTS
    Aisha Alzuhair (ASAN Medical Center, Saudi Arabia)
  • ROBOTIC VERSUS CONVENTIONAL NIPPLE SPARING MASTECTOMY AND IMMEDIATE PROSTHESIS BREAST RECONSTRUCTION IN THE MANAGEMENT OF BREAST CANCER- A CASE CONTROL COMPARISON STUDY
    Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
  • PHASE II RANDOMIZED STUDY OF NEOADJUVANT METFORMIN PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR ER-POSITIVE POSTMENOPAUSAL BREAST CANCER [METEOR STUDY]
    Jisun Kim (ASAN Medical Center, Korea)
  • DEAD-BOX RNA HELICASE DP103 REGULATED SUMO/ACETYLATION SWITCH OF P53 DETERMINES RESPONSE TO DOCETAXEL IN ERα-POSITIVE BREAST CANCER
    Alan Prem Kumar (National Univ. of Singapore, Singapore)
Oral Presentation 2
Venue: 104-106
  • THE RISK OF CARDIAC DISEASE IN KOREAN BREAST CANCER PATIENTS: IMPACT OF PATIENT-SPECIFIC FACTORS AND HEART DOSE BASED ON INDIVIDUAL HEART DOSE CALCULATION FROM THREE-DIMENSIONAL RT PLANNING
    Seung Yeun Chung (Yonsei Univ. College of Medicine, Korea)
  • INTERNAL MAMMARY LYMPH NODES INVOLVEMENT IN PATIENTS WITH BREAST CANCER: ANATOMICAL CHARACTERISTICS AND IMPLICATION FOR TARGET DELINEATION
    Yujie Wang (Shanghai Jiaotong Univ. Medical School Ruijin Hospital, China)
  • RISK OF LYMPHEDEMA FOLLOWING CONTEMPORARY TREATMENT FOR BREAST CANCER: AN ANALYSIS OF 7,426 CONSECUTIVE PATIENTS FROM A MULTIDISCIPLINARY PERSPECTIVE
    Hwa Kyung Byun (Yonsei Univ. College of Medicine, Korea)
  • RADIATION PRACTICE PATTERNS AND IMPACT OF RADIOTHERAPY ON COMPLICATIONS AFTER BREAST RECONSTRUCTION: FINAL REPORT OF KROG 18-04
    Jee Suk Chang (Yonsei Univ. College of Medicine, Korea)
  • EFFECT OF POLOXAMER-BASED THERMO-SENSITIVE SOL-GEL ON SHOULDER MOTION AFTER AXILLARY LYMPH NODE DISSECTION IN PATIENTS WITH BREAST CANCER: A MULTI-CENTER DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL
    Hee Jun Choi (Samsung Changwon Hospital, Korea)
  • GAS VERSUS GASLESS ROBOT-ASSISTED NIPPLE SPARING MASTECTOMY
    Jeea Lee (Yonsei Univ. College of Medicine, Korea)
  • PRE-OPERATIVE TOMOSYNTHESIS-GUIDED HOOKWIRE NEEDLE LOCALISATION OF IMPALPABLE, MAMMOGRAPHICALLY AND SONOGRAPHICALLY OCCULT BREAST LESIONS: A PRELIMINARY EXPERIENCE
    Victor Chan (Queen Mary Hospital, Hong Kong)
  • OUTCOMES OF DUCTAL CARCINOMA IN SITU ACCORDING TO DETECTION MODALITY: A MULTICENTER STUDY COMPARING RECURRENCE BETWEEN MAMMOGRAPHY AND BREAST US
    Jung Hyun Yoon (Yonsei Univ. College of Medicine, Korea)
11:30-12:15
Plenary Lecture 1
Venue: Premier Ballroom AB
  • Evolution of Therapeutic Strategies for Hormone Receptor-positive, HER2-negative Breast Cancer
    Nadia Harbeck (Univ. of Munich (LMU), Germany)
12:30-13:15
Satellite Symposium 1
Venue: Premier Ballroom AB
  • Leading the Way in the Treatment of HR+ HER2-mBC: Palbociclib & CDK4/6 Inhibitors in Clinical Practice
    Hope S. Rugo (Univ. of California San Francisco Medical Center, U.S.A.)
13:45-14:30
Plenary Lecture 2
Venue: Premier Ballroom AB
  • Current Trends and Future Directions in Bench to Bedside Translational Research in ER-positive Breast Cancer
    Carlos Arteaga (UT Southwestern Harold C. Simmons Cancer Center, U.S.A.)
14:45-16:00
Symposium 2
TNBC: Where Are We and What’s Next Destination?
Venue: Premier Ballroom AB
  • Potential Therapeutic Targets: Androgen Receptor, PI3KCA, MEK, etc.
    Sung-Bae Kim (ASAN Medical Center, Korea)
  • BRCA and DNA Repair Impairment
    Seock-Ah Im (Seoul National Univ. Hospital, Korea)
  • Optimal Treatment of TNBC with Cytotoxic Chemotherapy
    Rebecca Alexandra Dent (National Cancer Centre Singapore, Canada)
Panel Discussion 2
Up-to-date Management of Premalignant Lesion
Venue: Premier Ballroom C
  • Risk Stratification of Premalignant Breast Lesions
    Aeree Kim (Korea Univ. Guro Hospital, Korea)
  • Surgery for Lobular Carcinoma in Situ: To Do or Not to Do?
    Masahiro Takada (Kyoto Univ. Hospital, Japan)
  • How to Manage Suspicious Microcalcifications?
    Jonghan Yu (Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)
Education Session 2
Prediction and Risk Assessment of Breast Imaging
Venue: 113-115
  • Quantitative Imaging for Breast Cancer Risk Assessment
    Emily Conant (Univ. of Pennsylvania, U.S.A.)
  • Early Prediction of Response from Neoadjuvant Therapy
    Bong Joo Kang (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
  • Application of AI in Diagnosis of Breast Cancer with Digital Mammography
    Eun-Kyung Kim (Yonsei Univ. Severance Hospital, Korea)
Survivorship Session 1
Healthy Living after Breast Cancer Treatment from Psycho-oncologists’ Perspectives
Venue: 107-109
  • Complex Relationship among Depression, Self-efficacy, Illness Perception, and Fear of Progression in Breast Cancer Survivors
    Eun-Jung Shim (Pusan National Univ., Korea)
  • Understanding the Causes of Distress in Breast Cancer Patients and Survivors
    Richard Fielding (Univ. of Hong Kong, Hong Kong)
  • Sleep & Depression: Two Important Psychiatric Symptoms in Psycho-oncology
    Seockhoon Chung (ASAN Medical Center, Korea)
Junior Doctors Forum 1
Venue: 104-106
  • My Journey with Endocrine Therapy and Future Perspectives on Young Asian Doctors
    Ian Smith (The Royal Marsden NHS Foundation Trust, United Kingdom)
16:15-17:30
Symposium 3
Immunity, Immunotherapy, and Breast Cancer
Venue: Premier Ballroom AB
  • Current Trends in Immuno-oncology
    Eui-Cheol Shin (Korea Advanced Institute of Science and Technology (KAIST), Korea)
  • Immunotherapy in Breast Cancer: Biomarkers and Correlative Studies
    Prudence Francis (Peter MacCallum Cancer Centre, Australia)
  • Breast Cancer Subtypes & Immunotherapy
    Giuseppe Curigliano (Istituto Europeo di Oncologia, Italy)
Panel Discussion 3
Breast Cancer and Bone Metastasis: from Microenvironment to Macroenvironment
Venue: Premier Ballroom C
  • Bone Physiology and Pathogenesis of Bone Metastasis
    Sun Wook Cho (Seoul National Univ. Hospital, Korea)
  • Surgical Consideration for Bone Metastasis from Breast Cancer
    Wanlim Kim (ASAN Medical Center, Korea)
  • Optimization of Radiation Therapy for Bone Metastasis
    Haeyoung Kim (Samsung Medical Center, Korea)
Education Session 3
Recent Advance of MRI and Its Application
Venue: 113-115
  • Abbreviated Breast MRI for High Risk Patients
    Christiane Katharina Kuhl (RWTH Aachen, Germany)
  • Non-contrast MRI for Screening and Surveillance of Breast Cancer
    Hee Jung Shin (ASAN Medical Center, Korea)
  • Application of Ultrafast MRI to Real Practice
    Nariya Cho (Seoul National Univ. Hospital, Korea)
Survivorship Session 2
Cancer Chronotherapy: A Right Time in the Day to Treat
Venue: 107-109
  • Association between Circadian Disruption and Breast Cancer
    Tae Kim (GIST (Gwangju Institute of Science and Technology), Korea)
  • Mutations in Circadian Genes and Their Mechanistic Connection to Cancer Development
    Carla Finkielstein (Virginia Tech, U.S.A.)
  • Circadian Rhythm of p53 toward the Chronotherapy of Cancer
    Jae Kyoung Kim (Korea Advanced Institute of Science and Technology (KAIST), Korea)
Junior Doctors Forum 2
How to Globalize the Society You Are Involved in
Venue: 104-106
  • How to Globalize the Society You Are Involved in
    Seigo Nakamura (Showa Univ. School of Medicine, Japan)
  • How to Globalize Your Career: 30 Years Experience from the Mind to the Global Stent Market
    Ho-Young Song (ASAN Medical Center, Korea)
  • Introduction to Journal of Breast Cancer
    Yongsik Jung (Ajou Univ. Hospital, Korea)
Back to Previous Meetings